NCT01812577

Brief Summary

Percutaneous radiofrequency ablation of liver lesions causes patients acute pain during and after the procedure. During the procedure patients need deep sedation and cannot be collaborative. Furthermore post-operative analgesia is necessary. The aim of this study is to evaluate if the ultrasound-guided paravertebral block (TPVB)with a single injection can provide anesthesia and post-operative analgesia in these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 18, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
8.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

August 23, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

March 8, 2013

Last Update Submit

August 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intensity of postoperative pain after radiofrequency ablation of liver lesion

    Intensity of postoperative pain after radiofrequency ablation of liver lesion is evaluated in both groups using VRS of pain at rest and in movement after 3-6-12-24 hours from procedure.

    first 24 post-operative hours

Secondary Outcomes (2)

  • Incidence of complications

    From procedure to 24 hours

  • Consumption of post-operative opioid

    Within 24 post-operative hours

Other Outcomes (1)

  • Satisfaction of patient and of the operator

    From the procedure to 24 hours later.

Study Arms (2)

Thoracic paravertebral block (TPVB)

Twenty patients receiving thoracic paravertebral block at level of T7, before the interventistic procedure.

Deep Sedation (DS)

Twenty patients receiving local and intravenous anesthesia during the procedure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

In this study 40 patients undergoing elective procedure of radiofrequency ablation of liver lesions are enrolled after written informed consent is obtained.

You may qualify if:

  • written consent ASA I-III

You may not qualify if:

  • allergy to local anesthetic infection in the site of planned injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Campus Bio-Medico

Rome, Italy/RM, 00121, Italy

Location

Related Publications (2)

  • Hara K, Sakura S, Nomura T, Saito Y. Ultrasound guided thoracic paravertebral block in breast surgery. Anaesthesia. 2009 Feb;64(2):223-5. doi: 10.1111/j.1365-2044.2008.05843.x. No abstract available.

    PMID: 19143711BACKGROUND
  • Renes SH, Bruhn J, Gielen MJ, Scheffer GJ, van Geffen GJ. In-plane ultrasound-guided thoracic paravertebral block: a preliminary report of 36 cases with radiologic confirmation of catheter position. Reg Anesth Pain Med. 2010 Mar-Apr;35(2):212-6. doi: 10.1097/aap.0b013e3181c75a8b.

    PMID: 20301827BACKGROUND

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Study Officials

  • Massimiliano Carassiti, MD

    Campus Bio Medico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 8, 2013

First Posted

March 18, 2013

Study Start

December 1, 2012

Primary Completion

December 1, 2013

Study Completion

September 1, 2022

Last Updated

August 23, 2024

Record last verified: 2024-08

Locations